Yuko Tanabe

2.8k total citations
107 papers, 1.8k citations indexed

About

Yuko Tanabe is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuko Tanabe has authored 107 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 33 papers in Molecular Biology and 23 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuko Tanabe's work include Cancer Immunotherapy and Biomarkers (10 papers), HER2/EGFR in Cancer Research (10 papers) and Cancer Treatment and Pharmacology (10 papers). Yuko Tanabe is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), HER2/EGFR in Cancer Research (10 papers) and Cancer Treatment and Pharmacology (10 papers). Yuko Tanabe collaborates with scholars based in Japan, United States and United Kingdom. Yuko Tanabe's co-authors include Takashi Momoi, Eriko Fujita, Mariko Y. Momoi, Kenji Tamura, Masatsugu Ueda, Noboru Yamamoto, Akira Shiota, Kan Yonemori, Kazunari Kaneko and Takanori Yamagata and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Yuko Tanabe

101 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuko Tanabe Japan	25	671	572	343	227	181	107	1.8k
Martin Begemann Germany	23	1.2k 1.7×	578 1.0×	193 0.6×	339 1.5×	168 0.9×	54	2.3k
George E. Farmer United States	17	957 1.4×	833 1.5×	199 0.6×	206 0.9×	127 0.7×	41	2.2k
C. Harker Rhodes United States	32	746 1.1×	408 0.7×	334 1.0×	264 1.2×	361 2.0×	65	2.8k
Marcela V. Karpuj United States	20	1.3k 1.9×	256 0.4×	254 0.7×	370 1.6×	371 2.0×	26	2.9k
Robert Lachmann Germany	19	1.3k 2.0×	312 0.5×	533 1.6×	256 1.1×	275 1.5×	39	2.9k
Carsten Riether Switzerland	29	722 1.1×	701 1.2×	162 0.5×	111 0.5×	108 0.6×	71	2.7k
Frédéric Brau France	20	678 1.0×	257 0.4×	159 0.5×	133 0.6×	176 1.0×	40	2.1k
Douglas E. Wright United States	18	935 1.4×	476 0.8×	176 0.5×	161 0.7×	453 2.5×	28	3.1k
Rainer Maier Switzerland	18	861 1.3×	221 0.4×	252 0.7×	180 0.8×	241 1.3×	25	1.9k
Sara Gil‐Perotín Spain	23	920 1.4×	266 0.5×	156 0.5×	154 0.7×	422 2.3×	44	2.4k

Countries citing papers authored by Yuko Tanabe

Since Specialization

Citations

This map shows the geographic impact of Yuko Tanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Tanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Tanabe more than expected).

Fields of papers citing papers by Yuko Tanabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Tanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Tanabe. The network helps show where Yuko Tanabe may publish in the future.

Co-authorship network of co-authors of Yuko Tanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Tanabe. A scholar is included among the top collaborators of Yuko Tanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Tanabe. Yuko Tanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Goto, Atsushi, Ken Ohashi, Mitsuhiko Noda, et al.. (2024). Third Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on diabetes and cancer: summary of the results of a questionnaire survey of oncologists and diabetologists—secondary publication. Diabetology International. 15(1). 5–18.

Kikawa, Yuichiro, Yukari Uemura, Tetsuhiko Taira, et al.. (2024). A randomized study comparing electronic patient-reported outcome (ePRO) monitoring with routine follow-up during trastuzumab deruxtecan treatment in patients with metastatic breast cancer (PRO-DUCE study).. Journal of Clinical Oncology. 42(16_suppl). 1504–1504. 1 indexed citations

Goto, Atsushi, Ken Ohashi, Mitsuhiko Noda, et al.. (2024). Third Report of the Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer: Summary of the results of a questionnaire survey of oncologists and diabetologists—Secondary publication. Cancer Science. 115(2). 672–681. 1 indexed citations

Takahashi, Masato, Yuichiro Kikawa, Kosuke Kashiwabara, et al.. (2024). Eribulin versus S-1 as first or second-line chemotherapy to assess health-related quality of life and overall survival in HER2-negative metastatic breast cancer (RESQ study): a non-inferiority, randomised, controlled, open-label, phase 3 trial. EClinicalMedicine. 74. 102715–102715. 3 indexed citations

Tanabe, Yuko, et al.. (2023). HIST1H1E syndrome with deficiency in multiple pituitary hormones. Clinical Pediatric Endocrinology. 32(3). 195–198. 1 indexed citations

Kitano, Atsuko, Naomi Sakurai, Yuko Tanabe, et al.. (2023). Factors associated with financial toxicity in patients with breast cancer in Japan: a comparison of patient and physician perspectives. Breast Cancer. 30(5). 820–830. 4 indexed citations

Yamanaka, T., Takeshi Yamaguchi, Yuko Tanabe, et al.. (2023). Bell's palsy during rechallenge of immune checkpoint inhibitor. IJU Case Reports. 6(2). 144–146. 3 indexed citations

Masuda, Hiroko, Yuko Tanabe, Koji Matsumoto, et al.. (2023). Efficacy of probiotics and trimebutine maleate for abemaciclib-induced diarrhea: A randomized, open-label phase II trial (MERMAID, WJOG11318B). The Breast. 71. 22–28. 13 indexed citations

Anan, Keisuke, Takayuki Ogura, Yuko Tanabe, et al.. (2021). Safety and harms of bronchoalveolar lavage for acute respiratory failure: A systematic review and meta-analysis. Respiratory Investigation. 60(1). 68–81. 6 indexed citations

10.

Miyake, Noriko, et al.. (2021). Expanding the phenotypic spectrum of cardiospondylocarpofacial syndrome: From a detailed clinical and radiological observation of a boy with a novel missense variant in MAP3K7. American Journal of Medical Genetics Part A. 188(1). 350–356. 2 indexed citations

11.

Kyo, Michihito, Koji Hosokawa, Shinichiro Ohshimo, et al.. (2020). Prognosis of pathogen-proven acute respiratory distress syndrome diagnosed from a protocol that includes bronchoalveolar lavage: a retrospective observational study. Journal of Intensive Care. 8(1). 54–54. 3 indexed citations

12.

Shimomura, Akihiko, Yuko Tanabe, Juntaro Matsuzaki, et al.. (2020). Peripheral neuropathy from paclitaxel: risk prediction by serum microRNAs. BMJ Supportive & Palliative Care. 14(e2). e1829–e1834. 8 indexed citations

13.

Kyo, Michihito, Keisuke Nishioka, Takaaki Nakaya, et al.. (2019). Unique patterns of lower respiratory tract microbiota are associated with inflammation and hospital mortality in acute respiratory distress syndrome. Respiratory Research. 20(1). 246–246. 62 indexed citations

14.

Oki, Ryosuke, Chihiro Kondoh, Yuji Miura, et al.. (2017). S-1 plus cisplatin combination therapy in patients with urachal carcinoma: A retrospective study. Annals of Oncology. 28. x84–x84.

15.

Kato, Shogo, Ken Yoshimura, Yuko Tanabe, et al.. (2013). A Child With Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis Complicated by Coronary Artery Lesion Mimicking Kawasaki Disease. Journal of Pediatric Hematology/Oncology. 35(7). e317–e319. 11 indexed citations

16.

Asahina, Hajime, Hiroshi Nokihara, Noboru Yamamoto, et al.. (2012). Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study. Investigational New Drugs. 31(3). 677–684. 33 indexed citations

17.

Fujita, Eriko, Yuko Tanabe, Takuya Miyakawa, et al.. (2010). Autism spectrum disorder is related to endoplasmic reticulum stress induced by mutations in the synaptic cell adhesion molecule, CADM1. Cell Death and Disease. 1(6). e47–e47. 75 indexed citations

18.

Hisajima, Tatsuya, Naho Maruyama, Yuko Tanabe, et al.. (2008). Protective effects of farnesol against oral candidiasis in mice. Microbiology and Immunology. 52(7). 327–333. 49 indexed citations

19.

Momoi, Mariko Y., et al.. (2007). Intracellular distribution of a speech/language disorder associated FOXP2 mutant. Biochemical and Biophysical Research Communications. 353(4). 869–874. 33 indexed citations

20.

Umeda, Tomoko, et al.. (2004). Clinical relevance of optineurin sequence alterations in Japanese glaucoma patients. Ophthalmic Genetics. 25(2). 91–99. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact